The reduction of pro-inflammatory cytokines, improvement in intestinal barrier integrity, and potential modulation of gut microbiota composition represent mechanisms that could theoretically complement existing IBD therapies
Key Takeaways: Mounjaro vs Ozempic Mounjaro (tirzepatide) shows higher average weight loss: 22.5% vs 14.9% for Ozempic (semaglutide) Mounjaro acts on two receptors (GLP-1 and GIP), Ozempic acts on one (GLP-1) Both are FDA-approved for type 2 diabetes, commonly used off-label for weight loss Side effects are similar: nausea, diarrhea, constipation, though Mounjaro may cause slightly more GI issues Brand prices: Mounjaro $1,069/month, Ozempic $969/month Compounded alternatives: tirzepatide $349/month, semaglutide $199/month through TrimRx Insurance coverage inconsistent for both when used for weight loss Most people tolerate both medications well after initial adjustment period What Are Mounjaro and Ozempic
PlexusDx patients have access to personalized support when managing constipation or other side effects
Every ingredient is carefully selected for quality and efficacy, and our product is NSF Certified for Sport, ensuring you're getting exactly what's on the label with no contaminants
Why Concentration is the Key Variable The most critical piece of information on your medication label is the concentration
Combining a GLP-1 receptor agonist and basal insulin: study evidence and practical considerations
